Fiona H. Marshall’s Post

📢 Exciting webinar alert! 📢 Don't miss this opportunity to learn how AI is revolutionizing antibody discovery. Join us Wednesday with Patsnap to explore the power of AI-driven tools and patent data in accelerating your research. Learn how curated data from patents can accelerate AI-based solutions and improves existing algorithms!!!! #biotech #antibody #insilico #AI #drugdiscovery #techbio

Is AI transforming antibody discovery? Join us on October 9 to explore the groundbreaking role of AI in antibody discovery and optimization. In this exclusive webinar with Patsnap and MAbSilico, you’ll learn about: ✨ AI-driven tools for faster, cost-effective antibody discovery ✨ The latest advancements in computational biology ✨ Extracting valuable data from patents to fuel research Don’t miss out on insights that could transform your R&D! Register now: https://lnkd.in/dNcaVb9q #Webinar #AI #Antibody #Lifesicnece #Biologics #Patsnap #MAbSilico

AI models, from statistics to LMM, need data and accurate data!!! Join us on Wednesday to learn how MAbSilico developed its solutions using the largest antibody curated database from patents. Anne and Sam will share their feedbacks on #datascience, #AI-based solutions and #antibodydiscovery during a webinar organized by Patsnap #biotech #techbio #insilico #antibody #patent

In the dynamic world of pharmaceuticals, AI-powered drug discovery is revolutionizing how we develop new therapies. By leveraging advanced algorithms and machine learning, AI can analyze vast datasets quickly, identifying potential drug candidates with greater accuracy and speed. This approach not only accelerates the discovery process but also uncovers novel drug candidates and repurposes existing drugs, offering faster and more precise treatment options. AI platforms like DeepMind's AlphaFold and companies like Insilico Medicine are already making significant strides, predicting protein structures and streamlining drug development stages. The integration of AI reduces the time and cost of bringing new drugs to market, crucial for tackling complex diseases like cancer and genetic disorders. As someone passionate about healthcare innovation, I am excited about the transformative potential of AI in pharmaceuticals and look forward to connecting with professionals in this field. #AI #DrugDiscovery #Pharmaceuticals #HealthcareInnovation #Biotech

Great brief review of AI-discovered drugs: 💡 Phase I AI-discovered molecules have a success rate of 80-90%, which is higher than historical industry averages Phase II data suggest a success rate of ∼40%, which is in line with historical industry averages. There is not enough data from Phase III trials, but it will be exciting to see how AI techniques will impact R&D productivity and drug discovery in the future. 🚀 Integration of multi-domain analysis of OMICs, phenotypic data, reverse translation and novel patient-derived model technologies could greatly improve AI drug discovery!! #AI #drugdiscovery #Immunotherapy #SyntheticBiology #CancerResearch #MedicalInnovation #CellTherapy #Aging #reimagingmedicine https://lnkd.in/eKYDnqpm

🚀 Revolutionising Drug Discovery with AI and Patient-on-Chip Technology! 🧬 Excited to share Pharma IQ's latest article on how AI and patient-on-chip technology are transforming drug discovery and development. Discover how these advancements are not only improving safety predictions but also paving the way for personalised medicine. 💡 As Isaac Bentwich from Quris AI explained in our interview with him: "Creating miniaturised versions of the human organs on microfluidic chips allows for more accurate simulations of human physiology, providing better predictions of drug interactions." Read the full article here: https://bit.ly/4fRvFPx Additionally, check out our comprehensive guide on Maximising ROI from Drug Discovery: https://bit.ly/3WgVteI 🔗 Don’t miss our upcoming event AI for Pharma & Healthcare, happening from 24-26 September in Amsterdam. Join us to explore the latest innovations and network with industry leaders. Register here: https://bit.ly/3W9SEvP Isaac Bentwich Quris AI Danielle Dougan #AIDrugDiscovery #PatientOnChip #PersonalizedMedicine #PharmaInnovation #HealthcareAI #DrugDevelopment #Biotech #Pharma

Learn from our CBO, COO, Maayan Elias Robicsek on how we use AI to transform drug discovery > #AI #drugdiscovery #peptides #drugdevelopment

Learn how our AI platform actually works to find superior peptide drug candidates in a fraction of the time and cost! Great post Maayan Elias Robicsek. #AI #drugdiscovery #peptides #drugdevelopment

“Driving Drug Discovery Efficiencies in Life Sciences with AI - with Anne Phelan of BenevolentAI” https://lnkd.in/e7gbtpr3 Today’s guest on the ‘AI in Healthcare and Life Sciences’ podcast is Anne Phelan, Chief Scientific Officer at BenevolentAI. BenevolentAI stands at the forefront of AI-enhanced drug discovery, utilizing cutting-edge technology to reveal new biology, identify novel targets, and forge treatments for complex diseases. Anne shares insights into her team's process for developing AI models that predict drug properties, stability, and pharmacological characteristics. This application of AI not only accelerates drug discovery but also increases the precision of these medicinal solutions. Later in the episode, the discussion expands to explore how similar technologies are applied to stratify patient data according to disease traits. This assists in matching the most promising drugs with the right patients, thereby optimizing clinical efficacy. #Healthcare #LifeSciences #AI #DrugDiscovery #BenevolentAI #TechnologyInMedicine #Pharmacology #ClinicalEfficacy #PatientData #DiseaseManagement #InnovationInHealth #ScientificInsight #MedicalResearch #TargetedTherapy #PrecisionMedicine

🌟 Join us at the AI in Drug Discovery Xchange - San Francisco 2024, where we bring together top executives from pharma and biotech to tackle key issues in AI Drug Discovery. 🌟 Secure your spot, and get a complimentary pass now! https://lnkd.in/eyepEgF8 We're thrilled to spotlight one of our distinguished facilitators: Pavan Ramkumar, Director of Machine Learning at Herophilus With a wealth of experience and groundbreaking insights, Pavan will lead a pivotal session on "Data Quality Costs and Expectations in Biotech, Techbio, and Pharma." 🗓️ Date: Thursday, September 26, 2024 🕗 Time: 08:00am - 05:35pm 📍 Venue: DoubleTree by Hilton, San Francisco Airport Key Discussion Points: 🔍 How different roles in biotech, techbio, and pharma view 'data' and 'quality.' 🧩 Main challenges in keeping data quality high throughout the drug discovery process. 🛠️ Approaches to maintaining data quality with diverse tools and expertise. 🚧 Common issues and solutions for managing data quality across different roles. 🎯 How effective current data quality roles and third-party solutions are in supporting AI-driven drug discovery. About Pavan Ramkumar: Pavan Ramkumar leads the machine learning team at Herophilus, focusing on brain organoid-based therapeutics for CNS disease. He is also the founder of Litquest, a startup creating a research tool for drug hunters. With a PhD in computational neuroscience and extensive experience in both academia and industry, Pavan brings valuable insights to the AI in Drug Discovery field. 📊💡 Don't miss the chance to learn from experts like Pavan and drive the future of drug discovery! 🚀 Secure your Complimentary Pass now! https://lnkd.in/eyepEgF8 #AIinDrugDiscovery #PharmaInnovation #Biotech #AI #DrugDiscovery #DataQuality #MachineLearning #BiotechEvents #Innovation #Networking #PharmaTech #TechBio #HealthcareAI #CNSDisease #Bioinformatics #ComputationalBiology #FutureOfMedicine #AIForGood #HealthTech #DrugDevelopment #LifeSciences #PharmaLeaders #BioPharma #ClinicalResearch #PharmaR&D #ResearchInnovation #MedicalAI #BiotechLeaders #ScientificDiscovery #HealthcareInnovation #PharmaTrends #DrugResearch #BioTechXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass